79 related articles for article (PubMed ID: 17558705)
1. All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication.
Maeda Y; Yamaguchi T; Hijikata Y; Morita Y; Tanaka M; Hirase C; Takai S; Tatsumi Y; Kanamaru A
Hematology; 2007 Jun; 12(3):263-6. PubMed ID: 17558705
[TBL] [Abstract][Full Text] [Related]
2. Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia.
Yamaguchi T; Maeda Y; Ueda S; Hijikata Y; Morita Y; Miyatake JI; Matsuda M; Kanamaru A
Leukemia; 2005 Jun; 19(6):1010-7. PubMed ID: 15843825
[TBL] [Abstract][Full Text] [Related]
3. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
[TBL] [Abstract][Full Text] [Related]
4. Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.
McMahon JB; Buckheit RW; Gulakowski RJ; Currens MJ; Vistica DT; Shoemaker RH; Stinson SF; Russell JD; Bader JP; Narayanan VL; Schultz RJ; Brouwer WG; Felauer EE; Boyd MR
J Pharmacol Exp Ther; 1996 Jan; 276(1):298-305. PubMed ID: 8558446
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 3'azido-3'deoxythymidine-resistant HIV-1 infection by dehydroepiandrosterone in vitro.
Yang JY; Schwartz A; Henderson EE
Biochem Biophys Res Commun; 1994 Jun; 201(3):1424-32. PubMed ID: 8024587
[TBL] [Abstract][Full Text] [Related]
6. De novo reverse transcription is a crucial event in cell-to-cell transmission of human immunodeficiency virus.
Li P; Kuiper LJ; Stephenson AJ; Burrell CJ
J Gen Virol; 1992 Apr; 73 ( Pt 4)():955-9. PubMed ID: 1378883
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.
Trabaud MA; Leriche-Guerin K; Regis C; Bordes I; Cotte L; Detmer J; Kolberg J; Ritter J; Trépo C
J Med Virol; 2000 Jul; 61(3):352-9. PubMed ID: 10861645
[TBL] [Abstract][Full Text] [Related]
8. Evolution of AZT resistance in HIV-1: the 41-70 intermediate that is not observed in vivo has a replication defect.
Jeeninga RE; Keulen W; Boucher C; Sanders RW; Berkhout B
Virology; 2001 May; 283(2):294-305. PubMed ID: 11336554
[TBL] [Abstract][Full Text] [Related]
9. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
[No Abstract] [Full Text] [Related]
10. [Chronically HIV-1 infected human monocyte culture U937 as a model for assessing the efficacy of anti-HIV agents].
Pokrovskiĭ AG; Pliasunova OA; Gashnikova NM; Mamaeva OA; Fediuk NV
Vopr Virusol; 2001; 46(6):38-42. PubMed ID: 11785387
[TBL] [Abstract][Full Text] [Related]
11. Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro.
Albright AV; Erickson-Viitanen S; O'Connor M; Frank I; Rayner MM; González-Scarano F
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1527-37. PubMed ID: 11054266
[TBL] [Abstract][Full Text] [Related]
12. Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells.
Njai HF; Lewi PJ; Janssen CG; Garcia S; Fransen K; Kestens L; Vanham G; Janssen PA
Antivir Ther; 2005; 10(2):255-62. PubMed ID: 15865220
[TBL] [Abstract][Full Text] [Related]
13. T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.
Ojwang JO; Buckheit RW; Pommier Y; Mazumder A; De Vreese K; Esté JA; Reymen D; Pallansch LA; Lackman-Smith C; Wallace TL
Antimicrob Agents Chemother; 1995 Nov; 39(11):2426-35. PubMed ID: 8585721
[TBL] [Abstract][Full Text] [Related]
14. Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.
García-Lerma JG; MacInnes H; Bennett D; Weinstock H; Heneine W
J Virol; 2004 Jul; 78(14):7545-52. PubMed ID: 15220429
[TBL] [Abstract][Full Text] [Related]
15. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
[TBL] [Abstract][Full Text] [Related]
16. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
[TBL] [Abstract][Full Text] [Related]
17. Failure of azidothymidine to inhibit human immunodeficiency virus (HIV) replication in a promonocytic cell line (U937).
Uherová P; Schmidtmayerová H; Mayer V
Acta Virol; 1991 Aug; 35(4):357-64. PubMed ID: 1724875
[TBL] [Abstract][Full Text] [Related]
18. Alpha-lipoic acid is an effective inhibitor of human immuno-deficiency virus (HIV-1) replication.
Baur A; Harrer T; Peukert M; Jahn G; Kalden JR; Fleckenstein B
Klin Wochenschr; 1991 Oct; 69(15):722-4. PubMed ID: 1724477
[TBL] [Abstract][Full Text] [Related]
19. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes.
Bergamini A; Perno CF; Balzarini J; Capozzi M; Marinelli L; Milanese G; Pesce CD; Calió R; Rocchi G
AIDS Res Hum Retroviruses; 1992 Jul; 8(7):1239-47. PubMed ID: 1381599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
